The single dose oral toxicity test revealed an LD50 of more than 2000 mg/kg.
In the repeat oral toxicity test, urinary examination revealed an increase in urine volume and a fall in specific gravity in both sexes of the 750 mg/kg group. Absolute or relative liver weights increased in males and females of the 750 mg/kg group and males of the 150 mg/kg group, absolute or relative kidney weights increased in males of the 150 and 750 mg/kg groups, and absolute and relative spleen weights decreased in females of the 750 mg/kg group. Macroscopically, enlargement of the liver was evident in males and females of the 750 mg/kg group, and enlargement and paleness of the kidneys were found in females of the 150 and 750 mg/kg groups. Histopathological examination revealed swelling of liver cells in both sexes of the 150 and 750 mg/kg groups and eosinophilic bodies in the renal tubules in males of the 150 and 750 mg/kg groups. These changes tended to recover with a 14 day recovery period. The NOEL for repeat dose toxicity is considered to be 30 mg/kg/day for both sexes.
Triisobutylene was not mutagenic in Salmonella typhimurium TA100, TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA. Neither structural nor numerical chromosomal aberrations were induced in CHL/IU cells up to the concentration going 50% cell growth inhibition or the limit concentration of 10 mM, in the absence or presence of an exogenous metabolic activation system.
Purity | : | 99.13% |
Test species/strain | : | Rat/Crj:CD (SD) |
Test method | : | OECD Test Guideline 401 |
Dosage | : | 2000 mg/kg |
Number of animals | : | Male, 5; female, 5/group |
Vehicle | : | Corn oil |
GLP | : | Yes |
Test results:
Purity | : | 99.13% |
Test species/strain | : | Rat/Crj:CD (SD) |
Test method | : | Guidelines for 28-day Repeat Dose Toxicity Testing of Chemicals (Japan) |
Route | : | Oral |
Dose | : | 0 (vehicle), 30, 150, 750 mg/kg/day |
Number of animals | : | Male, 5; female, 5 /group |
Vehicle | : | Corn oil |
Administration period | : | Male and female, 28 days |
Terminal kill | : | Male and female, days 29 or 43 |
GLP | : | Yes |
The NOEL is considered to be 30 mg/kg/day for both males and females under the conditions of the present study.
Purity | : | 99.13% |
Test species/strains | : | S.typhimurium TA100, TA1535, TA98, TA1537 E. coli WP2 uvrA |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Procedures | : | Plate incorporation method |
Solvent | : | Acetone |
Positive controls | : | -S9, AF-2 (TA100, WP2, TA98), sodium azide (TA1535) and 9-aminoacridine (TA1537) +S9, 2-aminoanthracene (all strains) |
Dosage | : | 0, 312.5, 625, 1250, 2500, 5000μg/plate |
S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 3 |
Number of replicates | : | 2 |
GLP | : | Yes |
Genetic effects:
S. typhimurium TA100, TA1535, TA 98, TA1537
+ | ? | - | |
with metabolic activation | [ ] | [ ] | [*] |
without metabolic activation | [ ] | [ ] | [*] |
E. coli WP2 uvrA
with metabolic activation | [ ] | [ ] | [*] |
without metabolic activation | [ ] | [ ] | [*] |
Purity | : | 99.13% |
Type of cell used | : | Chinese hamster CHL/IU cells |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Solvent | : | Acetone |
Positive controls | : | -S9, Mitomycin C +S9, Cyclophosphamide |
Dosage | : | -S9 (continuous treatment): 0, 0.005, 0.011, 0.021 mg/ml -S9 (short-term treatment): 0, 0.0011, 0.0021, 0.0042 mg/ml +S9 (short-term treatment): 0, 0.43, 0.85, 1.70 mg/ml |
S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 2 |
GLP | : | Yes |
clastogenicity | polyploidy | |||||
+ | ? | - | + | ? | - | |
without metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
with metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
1) | The tests were performed by the Biosafety Research Center, Foods, Drugs and Pesticides (An-pyo Center), 582-2 Shioshinden Arahama, Fukude-cyo,Iwata-gun, Shizuoka 437-12, Japan. Tel +81-538-58-1266 Fax +81-538-58-1393 |
2) | The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa 257, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627 |